You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Reactogenicity

Showing 1 - 25 of 1,502
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Zoster, Systemic Lupus Erythematosus, Vaccine Reaction Trial in Seoul (Shingrix, Placebo)

Recruiting
  • Zoster
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 17, 2023

Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)

Not yet recruiting
  • Herpes Simplex
  • HSVTI Formulation 1
  • +2 more
  • Tokyo, Japan
    GSK Investigational Site
Aug 4, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)

Completed
  • Vaccine-Preventable Diseases
  • Hepatitis B
  • CVI-HBV-002
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA University Bundang Medical Center
Nov 19, 2023

COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • QTP104 1ug
  • +2 more
  • Seoul, Korea, Republic of
  • +1 more
May 24, 2023

Vaccine Reaction Trial in Cincinnati (Venezuelan Equine Encephalitis DNA Vaccine, PharmaJet Stratis Needle-free Injection

Not yet recruiting
  • Vaccine Reaction
  • Venezuelan Equine Encephalitis DNA Vaccine
  • +2 more
  • Cincinnati, Ohio
    Velocity Clinical Research
Aug 15, 2023

COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

Not yet recruiting
  • COVID-19 Vaccine
  • COVID-19
  • 50 μg Baiya SARS-CoV-2 Vax 2
  • Placebo
  • Bangkok, Thailand
    Queen Saovabha Memorial Institute
May 23, 2023

SARS-CoV-2 Vaccine Tolerability and Clinical Outcome Among

Completed
  • SARS-CoV2 Infection
  • +3 more
  • IM injection of vaccination (mRNA vaccination)
  • IM injection of vaccination (vector based vaccination)
  • Hildesheim, Niedersachsen, Germany
    Helios Hospital Hildesheim
Dec 29, 2022

Influenza Trial in Saint Louis (mRNA-1010, Egg-based Quadrivalent Influenza Vaccine, Adjuvanted Quadrivalent Influenza Vaccine)

Recruiting
  • Influenza
  • mRNA-1010
  • +3 more
  • Saint Louis, Missouri
    Washington University in St. Louis
Nov 4, 2022

Healthy Volunteers Trial in Miami, Omaha (RBI-4000, RabAvert)

Recruiting
  • Healthy Volunteers
  • RBI-4000
  • RabAvert
  • Miami, Florida
  • +1 more
Sep 20, 2023

Cytomegalovirus Infection Trial in North Hollywood, San Diego, Honolulu (mRNA-1647, Placebo)

Active, not recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • North Hollywood, California
  • +2 more
Dec 3, 2022

Covid19 Trial in Auckland, Christchurch (Recombinant two-component COVID-19 vaccine (CHO cell), Placebo)

Completed
  • Covid19
  • Recombinant two-component COVID-19 vaccine (CHO cell)
  • Placebo
  • Auckland, New Zealand
  • +1 more
Sep 26, 2022

HIV I Infection Trial in United States (VIR-1388, Placebo)

Not yet recruiting
  • HIV I Infection
  • VIR-1388
  • Placebo
  • Birmingham, Alabama
  • +5 more
May 2, 2023

Severe Acute Respiratory Syndrome, Coronavirus, SARS-CoV-2 Trial in Belgium, Germany (CVnCoV Vaccine, Placebo)

Completed
Has Results
  • Severe Acute Respiratory Syndrome
  • +3 more
  • CVnCoV Vaccine
  • Placebo
  • Ghent, Belgium
  • +3 more
Apr 29, 2022

COVID-19 Vaccines Trial in Hannover (MVA-SARS-2-ST)

Recruiting
  • COVID-19 Vaccines
  • MVA-SARS-2-ST
  • Hannover, Germany
    Hannover Medical School ZKS - Early Clinical Trial Unit at CRC H
Sep 6, 2022

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • PCV20
  • (no location specified)
May 18, 2023

Influenza Trial in United States (mRNA-1010, mRNA-1010.4, mRNA-1010.6)

Recruiting
  • Influenza
  • mRNA-1010
  • +2 more
  • Hollywood, Florida
  • +9 more
May 11, 2023

COVID-19 Vaccine Trial in Bangkok (25 Baiya SARS-CoV-2 Vax 2, 50 Baiya SARS-CoV-2 Vax 2)

Active, not recruiting
  • COVID-19 Vaccine
  • 25 Baiya SARS-CoV-2 Vax 2
  • 50 Baiya SARS-CoV-2 Vax 2
  • Bangkok, Thailand
    Queen Saovabha Memorial Institute
Aug 8, 2022

COVID-19 Trial ("Sputnik Lite" vaccine for the prevention of COVID-19 with altered antigenic composition)

Not yet recruiting
  • COVID-19
  • "Sputnik Lite" vaccine for the prevention of COVID-19 with altered antigenic composition
  • (no location specified)
Sep 26, 2023

Gastroenteritis Trial in China (GSK's liquid oral live attenuated HRV, PCV-free liquid formulation of GSK's oral live attenuated

Recruiting
  • Gastroenteritis
  • GSK's liquid oral live attenuated HRV
  • PCV-free liquid formulation of GSK's oral live attenuated HRV
  • Chengdu, Sichuan, China
  • +7 more
Sep 7, 2023

COVID-19 Trial (GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition)

Not yet recruiting
  • COVID-19
  • GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition
  • (no location specified)
Oct 4, 2023

Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single

Not yet recruiting
  • Safety of a Single Dose of COMVIGEN Vaccine
  • +5 more
  • Comvigen (Bivalent, ChulaCov19 BNA159.2)
  • BIVALENT Pfizer/BNT vaccine
  • Bangkok, Thailand
  • +1 more
Jun 29, 2023

COVID-19 Pandemic Trial (A Lyophilized COVID-19 mRNA Vaccine, Placebo)

Not yet recruiting
  • COVID-19 Pandemic
  • A Lyophilized COVID-19 mRNA Vaccine
  • Placebo
  • (no location specified)
May 5, 2022

Smallpox, Monkeypox, Cowpox Trial in Koltsovo, Novosibirsk (VAC?6 vaccine (107 PFU), VAC?6 vaccine (106 PFU), Live Smallpox

Completed
  • Smallpox
  • +3 more
  • VAC∆6 vaccine (10⁷ PFU)
  • +3 more
  • Koltsovo, Novosibirsk Region, Russian Federation
  • +1 more
Apr 25, 2023

COVID-19 Trial (GBP510 adjuvanted with AS03, Placebo (Normal Saline))

Not yet recruiting
  • COVID-19
  • GBP510 adjuvanted with AS03
  • Placebo (Normal Saline)
  • (no location specified)
Aug 11, 2022